← All Sponsors
SPONSOR

Margaret Gatti-Mays

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Anatomic Stage IV Breast Cancer AJCC v8HER2-Negative Breast Carcinoma
NCT06026657 Phase 1, Phase 2
Recruiting

Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8
United States View Trial →